Rocklatan
Payments companies reported to CMS as associated with Rocklatan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rocklatan, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rocklatan
These are the largest totals companies reported as associated with Rocklatan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amy Miller | Dayton, OH | Ophthalmology | $178,309.93 |
| Jason Bacharach | Petaluma, CA | Glaucoma Specialist | $81,507.18 |
| Analisa Arosemena | Miami Beach, FL | Glaucoma Specialist | $77,318.41 |
| Joseph Panarelli | New York, NY | Ophthalmology | $72,476.74 |
| Gagan Sawhney | Atlanta, GA | Ophthalmology | $65,055.21 |
| Constance Okeke | Norfolk, VA | Ophthalmology | $63,564.57 |
| Gregory Katz | Ypsilanti, MI | Ophthalmology | $56,664.21 |
| Bac Nguyen | Houston, TX | Ophthalmology | $53,089.35 |
| Inder Singh | Racine, WI | Ophthalmology | $51,729.87 |
| Ahmad Aref | Chicago, IL | Ophthalmology | $44,852.35 |
Prescribed Rocklatan?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.